Pazopanib doses up to 2000 mg have been evaluated in clinical studies. Grade 3 fatigue (dose-limiting toxicity) and Grade 3 hypertension were each observed in 1 of 3 patients dosed at 2000 mg and 1000 mg daily, respectively.
There is no specific antidote for overdose with pazopanib and treatment of overdose should consist of general supportive measures.
Sign Out